XOMA Royalty (XOMA) Change in Acquisitions & Divestments (2012 - 2025)

XOMA Royalty's (XOMA) quarterly Change in Acquisitions & Divestments came in at $1000.0 in Q4 2025, down 99.99% quarter-over-quarter from $7.0 million in Q3 2025.

XOMA Royalty (XOMA) Change in Acquisitions & Divestments (2012 - 2025) Analysis & Trends

XOMA Royalty has disclosed Change in Acquisitions & Divestments across 4 years of filings, most recently posting $1000.0 for Q4 2025.

  • Change in Acquisitions & Divestments for Q4 2025 came in at $1000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $12.0 million (changed N/A YoY), and the FY2025 annual result was $7.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments came in at $1000.0 for Q4 2025 at XOMA Royalty, down from $7.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $7.0 million in Q3 2025 to a low of $1000.0 in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 XOMA Royalty 5.48 Mn -60.60 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,000.00
Dec 31, 2025 1,000.00
Sep 30, 2025 7.00 Mn
Sep 30, 2025 7.00 Mn
Dec 31, 2014 5.00 Mn
Dec 31, 2014 5.00 Mn
Sep 30, 2014 5.00 Mn
Sep 30, 2014 5.00 Mn
Jun 30, 2014 10.00 Mn
Jun 30, 2014 10.00 Mn
Jun 30, 2013 20.00 Mn
Jun 30, 2013 20.00 Mn
Mar 31, 2013 20.00 Mn
Mar 31, 2013 20.00 Mn
Dec 31, 2012 17.00 Mn
Dec 31, 2012 17.00 Mn